MedPath

Predictors of psoriasis on response to systemic therapy

Conditions
L40
Psoriasis
Registration Number
DRKS00017896
Lead Sponsor
AbbVie Deutschland GmbH & Co. KG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
381
Inclusion Criteria

Adult patients (= 18 years) with moderate to severe plaque psoriasis (defined by the European Consensus 2011 [5]) and present indication for conventional systemic psoriasis treatment (fumaric acid ester, MTX, cyclosporine, etc.) who are naive (untreated) to conventional psoriasis system therapy at the time of initiation of observation.

Exclusion Criteria

Patients who have already been treated with systemic psoriasis medications, i.e. are not naive to systemic psoriasis therapy and/or patients who are receiving PUVA therapy and/or patients who cannot or do not wish to sign the informed consent form

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Document the achievement of the 2011 European Consensus defined treatment goals after initial cessation of systemic treatment in the practical Routine<br><br>2. Assess whether or how the following basic parameters influence the achievement of treatment goals or disease course: <br>- severity of disease/extent of skin lesions<br>- quality of life (QoL)<br>- body weight, body mass index, waist and hip circumference, waist-hip ratio diagnosis of hypertension, type I/II diabetes mellitus, hyperlipidaemia<br>- history of disease with myocardial infarction stroke<br>- psoriatic arthritis, tobacco consumption<br>
Secondary Outcome Measures
NameTimeMethod
1. Observe the achievement of treatment goals related to other parameters, including:<br>- Psoriasis-associated parameters (age, nail PsO, scalp PsO, age at onset of disease, disease duration concomitant medication (other diseases)<br>2. Period and number of change of regimen related to the above baseline parameters<br>
© Copyright 2025. All Rights Reserved by MedPath